Document is current
Any future updates will be listed below
-
Authors
Zhang, Tian
Fu, Weixin
Zhang, Haosong https://orcid.org/0009-0006-7482-2607
Li, Jianlong
Xing, Beizi
Cai, Yuping
Zhang, Mengmeng
Liu, Xuheng
Qi, Chunting
Qian, Lihui
Hu, Xinbo
Zhu, Hua
Yang, Shuailong
Zhang, Min
Liu, Jianping https://orcid.org/0000-0001-7090-2112
Li, Ganquan
Li, Yang
Xiang, Rong
Qi, Zhengqiang
Hu, Junhao
Li, Ying https://orcid.org/0000-0002-3506-1255
Zou, Chengyu
Wang, Qin
Jin, Xia
Pang, Rui
Li, Peiying
Liu, Junli https://orcid.org/0000-0001-8861-3706
Zhang, Yaoyang https://orcid.org/0000-0001-5363-9834
Wang, Zhaoyin
Zhu, Zheng-Jiang https://orcid.org/0000-0002-3272-3567
Shan, Bing
Yuan, Junying https://orcid.org/0000-0003-2405-6036
- License Information
-
More Information
Article History
Received: 9 November 2023
Accepted: 19 September 2024
First Online: 7 November 2024
Competing interests
: J.Y., B.S. and T.Z. have filed a patent (Use of RIPK1 inhibitors in the prevention and treatment of vascular injury and diabetes. Patent application no. 202410916336.6; 2024). The other authors declare no competing interests.
